• Explore /
  • Poster
  • / S1406: Randomized phase II study of irinotecan and cetuximab with or without vemurafenib in <i>BRAF</i>-mutant metastatic colorectal cancer (mCRC).

S1406: Randomized phase II study of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (mCRC).

Abstract Poster

Authors

null

Scott Kopetz

The University of Texas MD Anderson Cancer Center, Houston, TX

Scott Kopetz , Shannon McDonough , Van Karlyle Morris II, Heinz-Josef Lenz , Anthony M. Magliocco , Chloe Evelyn Atreya , Luis A. Diaz Jr., Carmen Joseph Allegra , Christopher Hanyoung Lieu , S. Gail Eckhardt , Thomas John Semrad , Kimberly Kaberle , Katherine Guthrie , Howard S. Hochster

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Cancers of the Colon, Rectum, and Anus

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT 02164916

Citation

J Clin Oncol 33, 2015 (suppl 3; abstr TPS790)

DOI

10.1200/jco.2015.33.3_suppl.tps790

Abstract #

TPS790

Poster Bd #

F28

Abstract Disclosures

Similar Posters

First Author: Samuel A. Jacobs

First Author: Chiara Cremolini

First Author: John H. Strickler

First Author: Jeremy David Shapiro